Flavonoids: Potential therapeutic agents for cardiovascular disease

• Published in: Heliyon Vol. 10; no. 12; p. e32563
• Main Authors: Liu, Yingxue, Luo, Jing, Peng, Lin, Zhang, Qi, Rong, Xi, Luo, Yuhao, Li, Jiafu
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 30.06.2024; Elsevier
• Subjects: Antioxidant; Bioavailability; Cardiovascular disease; Flavonoid; Inflammation; Review; Cardiovascular disease; Inflammation; Bioavailability; Antioxidant; Flavonoid
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e32563

Flavonoids are found in the roots, stems, leaves, and fruits of many plant taxa. They are related to plant growth and development, pigment formation, and protection against environmental stress. Flavonoids function as antioxidants and exert anti-inflammatory effects in the cardiovascular system by modulating classical inflammatory response pathways, such as the TLR4-NF-ĸB, PI3K-AKT, and Nrf2/HO-1 signalling pathways. There is increasing evidence for the therapeutic effects of flavonoids on hypertension, atherosclerosis, and other diseases. The potential clinical value of flavonoids for diseases of the cardiovascular system has been widely explored. For example, studies have evaluated the roles of flavonoids in the regulation of blood pressure via endothelium-dependent and non-endothelium-dependent pathways and in the regulation of myocardial systolic and diastolic functions by influencing calcium homeostasis and smooth muscle-related protein expression. Flavonoids also have hypoglycaemic, hypolipidemic, anti-platelet, autophagy, and antibacterial effects. In this paper, the role and mechanism of flavonoids in cardiovascular diseases were reviewed in order to provide reference for the clinical application of flavonoids in the future.